PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33609560-0	2021	Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway.	fangchinoline	0-13	mechanistic target of rapamycin kinase	Homo sapiens	103-107	
35176991-3	2022	OBJECTIVE: This study aimed to identify the potential role of Fangchinoline in the treatment of SS via altering Akt/mTOR signaling.	fangchinoline	62-75	mechanistic target of rapamycin kinase	Homo sapiens	116-120	
35176991-10	2022	In vitro, Fangchinoline and LY294002 inhibited proliferation, induced cell cycle arrest, and promoted apoptosis in Raji and Daudi cells by altering Akt/mTOR signaling.	fangchinoline	10-23	mechanistic target of rapamycin kinase	Homo sapiens	152-156	
32201213-3	2020	Here, we revealed that fangchinoline (FCL), an active alkaloid that purified from the traditional Chinese medicine Stephania tetrandra S. Moore, enhanced the anti-lung cancer effect of mTOR inhibitor everolimus (EVE).	fangchinoline	23-36	mechanistic target of rapamycin kinase	Homo sapiens	185-189	
32201213-3	2020	Here, we revealed that fangchinoline (FCL), an active alkaloid that purified from the traditional Chinese medicine Stephania tetrandra S. Moore, enhanced the anti-lung cancer effect of mTOR inhibitor everolimus (EVE).	fangchinoline	38-41	mechanistic target of rapamycin kinase	Homo sapiens	185-189	
28968601-9	2017	Additionally, we observed that Fcn treatment inhibited mTOR and reduced the intracellular ATP levels.	fangchinoline	31-34	mechanistic target of rapamycin kinase	Homo sapiens	55-59